pI: 8.3198 |
Length (AA): 4257 |
MW (Da): 457329 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 7 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
374 | 456 | 2khm (A) | 29 | 114 | 42.00 | 0.0015 | 0.08 | 0.321197 | 0.72 |
911 | 1053 | 4lsw (A) | 107 | 258 | 33.00 | 0.96 | 0.63 | 0.103292 | 0.89 |
1191 | 1267 | 5fuc (C) | 116 | 199 | 39.00 | 0.43 | 0.28 | 0.275788 | 0.36 |
2772 | 3767 | 3iay (A) | 99 | 984 | 16.00 | 0 | 1 | 0.117368 | 1.45 |
2824 | 3933 | 5exr (C) | 375 | 1391 | 14.00 | 0 | 0.8 | 0.008147 | 1.81 |
3265 | 3599 | 5mdn (A) | 373 | 607 | 36.00 | 0.0000000017 | 1 | -0.0106061 | 0.85 |
3301 | 3607 | 2gv9 (A) | 701 | 951 | 35.00 | 0 | 1 | -0.0281835 | 0.86 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | ME49 Oocyst. | Fritz HM |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | VEG Tachyzoite, ME49 Tachyzoite, ME49 Bradyzoite. | Gregory Sibley/Greg |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 0-20% percentile | ME49 merozoite. | Hehl AB |
Sibley/Greg | ToxoDB |
Gregory | ToxoDB |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Ortholog group members (OG5_128651)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G67500 | DNA polymerase zeta subunit |
Arabidopsis thaliana | AT1G55040 | Zn-finger in Ran binding domain-containing protein |
Babesia bovis | BBOV_III010120 | DNA polymerase family B family protein |
Brugia malayi | Bm1_09315 | DNA polymerase family B containing protein |
Candida albicans | CaO19.7389 | similar to N terminus of S. cerevisiae REV3 (YPL167C) DNA polymerase zeta subunit involved in DNA repair |
Candida albicans | CaO19.7390 | similar to C terminus of S. cerevisiae REV3 (YPL167C) DNA polymerase zeta subunit involved in DNA repair |
Caenorhabditis elegans | CELE_Y37B11A.2 | Protein Y37B11A.2 |
Dictyostelium discoideum | DDB_G0271608 | DNA polymerase zeta catalytic subunit |
Drosophila melanogaster | Dmel_CG1925 | mutagen-sensitive 205 |
Echinococcus granulosus | EgrG_000149300 | DNA polymerase zeta catalytic subunit |
Entamoeba histolytica | EHI_068010 | DNA polymerase zeta catalytic subunit, putative |
Echinococcus multilocularis | EmuJ_000149300 | DNA polymerase zeta catalytic subunit |
Homo sapiens | ENSG00000009413 | REV3-like, polymerase (DNA directed), zeta, catalytic subunit |
Leishmania braziliensis | LbrM.23.1450 | DNA polymerase zeta catalytic subunit, putative |
Leishmania donovani | LdBPK_231590.1 | DNA polymerase zeta catalytic subunit, putative |
Leishmania infantum | LinJ.23.1590 | DNA polymerase zeta catalytic subunit, putative |
Leishmania major | LmjF.23.1330 | DNA polymerase zeta catalytic subunit, putative |
Leishmania mexicana | LmxM.23.1330 | DNA polymerase zeta catalytic subunit, putative |
Loa Loa (eye worm) | LOAG_13925 | hypothetical protein |
Loa Loa (eye worm) | LOAG_14745 | hypothetical protein |
Loa Loa (eye worm) | LOAG_11287 | hypothetical protein |
Loa Loa (eye worm) | LOAG_12098 | hypothetical protein |
Mus musculus | ENSMUSG00000019841 | REV3-like, catalytic subunit of DNA polymerase zeta RAD54 like (S. cerevisiae) |
Neospora caninum | NCLIV_040490 | DNA polymerase (EC 2.7.7.7), related |
Oryza sativa | 4342984 | Os07g0404300 |
Onchocerca volvulus | OVOC2477 | DNA polymerase homolog |
Saccharomyces cerevisiae | YPL167C | Rev3p |
Schistosoma japonicum | Sjp_0210840 | ko:K02350 DNA polymerase zeta subunit, putative |
Schistosoma japonicum | Sjp_0210830 | expressed protein |
Schistosoma mansoni | Smp_125680 | DNA polymerase zeta catalytic subunit |
Schmidtea mediterranea | mk4.001967.04 | |
Schmidtea mediterranea | mk4.001967.03 | DNA polymerase |
Schmidtea mediterranea | mk4.001967.02 | DNA polymerase |
Trypanosoma brucei gambiense | Tbg972.8.3050 | DNA polymerase zeta catalytic subunit, putative |
Trypanosoma brucei | Tb927.8.3290 | DNA polymerase zeta catalytic subunit, putative |
Trypanosoma congolense | TcIL3000_8_3340 | DNA polymerase zeta catalytic subunit, putative |
Trypanosoma cruzi | TcCLB.509769.130 | DNA polymerase zeta catalytic subunit, putative |
Toxoplasma gondii | TGME49_264670 | DNA polymerase family B protein |
Trichomonas vaginalis | TVAG_328140 | DNA polymerase alpha catalytic subunit, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.8.3290 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.3290 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.3290 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.8.3290 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
TGME49_264670 this record | Toxoplasma gondii | Essentiality uncertain | sidik |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.5